GOG 3026 A phase II trial of letrozole + ribociclib in women with recurrent low-grade serous carcinoma of the ovary, fallopian tube or peritoneum: A GOG foundation study (001)
Open Access
- 22 September 2023
- journal article
- abstracts
- Published by Elsevier in Gynecologic Oncology
- Vol. 176, S2